Table 2

Preoperative comorbidities in patients undergoing hip fracture surgery with spinal or general anesthesia.

Spinal anesthesia (n=1463)General anesthesia (n=974)P value
Myocardial infarction, n (%)225 (15.4)155 (15.9)0.765
Congestive heart failure, n (%)265 (18.1)160 (16.4)0.308
Peripheral vascular disease, n (%)110 (7.5)69 (7.1)0.746
Cerebrovascular disease, n (%)360 (24.6)233 (23.9)0.735
Dementia, n (%)360 (24.6)211 (21.7)0.103
COPD, n (%)139 (9.5)84 (8.6)0.507
Connective tissue disease, n (%)29 (2.0)11 (1.1)0.144
Peptic ulcer disease, n (%)128 (8.7)121 (12.4)0.004
Liver disease, n (%)11 (0.8)20 (2.1)0.009
Diabetes mellitus, n (%)0.851
 Uncomplicated98 (6.7)63 (6.5)
 End-organ damage123 (8.4)88 (9.0)
Hemiplegia, n (%)40 (2.7)29 (3.0)0.818
Chronic kidney disease, n (%)106 (7.2)71 (7.3)1.00
Cancer, n (%)0.297
 Local tumor298 (20.4)185 (19.0)
 Metastatic37 (2.5)34 (3.5)
Leukemia, n (%)10 (0.7)7 (0.7)1.00
Lymphoma, n (%)8 (0.5)4 (0.4)0.772
  • COPD, chronic obstructive pulmonary disease.;